Showing results (1-10 of 171) with videos related to
Sort By:
Pageof 18
Therapeutics and Clinical Risk Management|September 24, 2011
Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiencyJohannes HäberleArchives of Biochemistry and Biophysics|May 1, 2013
Clinical and biochemical aspects of primary and secondary hyperammonemic disordersJohannes HäberleExpert Review of Endocrinology & Metabolism|February 21, 2019
Carglumic acid for the treatment of N-acetylglutamate synthase deficiency and acute hyperammonemiaJohannes HäberleEuropean Journal of Pediatrics|December 18, 2010
Clinical practice: the management of hyperammonemiaJohannes HäberleJournal of Mother and Child|November 12, 2020
Primary hyperammonaemia: Current diagnostic and therapeutic strategiesJohannes HäberleJournal of Inherited Metabolic Disease|July 12, 2024
Citrin deficiency-The East-side storyJohannes HäberleJournal of Inherited Metabolic Disease|October 30, 2025
Nitrogen Scavengers: History, Clinical Considerations and Future ProspectsSven Klassa, Johannes HäberleJIMD Reports|February 19, 2015
Evaluation of Implementation, Adaptation and Use of the Recently Proposed Urea Cycle Disorders GuidelinesJohannes Häberle, Martina HuemerMolecular Genetics and Metabolism|January 9, 2026
Disease or non-disease - about the identification of metabolic conditions that require no treatmentJörn Oliver Sass, Johannes HäberleExpert Opinion on Therapeutic Targets|March 11, 2017
Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorderCarmen Diez-Fernandez, Johannes HäberlePageof 18